COVID Antibody Products May Get To Use Viral Load As Surrogate For Mutant-Targeted Versions

 
• By Sue Sutter
  
Footrace
Monoclonal antibody developers and regulators are trying to keep up with changes in the coronavirus that causes COVID-19. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from Pathways & Standards